ArticleJournal of medicinal chemistry2021

A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.

Sarah Wagner-Griffin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.